Detalhe da pesquisa
1.
Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites.
Clin Gastroenterol Hepatol;
14(10): 1463-1472.e6, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27317851
2.
Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.
Liver Int;
35(7): 1853-61, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25533197
3.
A population-based study on the prevalence of NASH using scores validated against liver histology.
J Hepatol;
60(4): 839-46, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24333862
4.
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol;
27(5): 951-6, 2012 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22141340
5.
Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
Diabetes;
63(1): 312-22, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24009255